What is the Thymus?

The thymus is an essential organ located directly behind the sternum and in between the lungs. Its main function is to foster the development of T-cells during childhood and puberty.

Before a child is born, the thymus is essential to an individual’s health, promoting a healthy immune system by creating T-cells which play an important role in the lymphatic and endocrine system. T-cells are an important piece of the body’s immune system as they help avoid bacterial and viral infections.

The thymus is divided into 3 main layers:

  • The capsule covers the outside of the thymus
  • The cortex surrounds the innermost section of the thymus
  • The medulla is the center of the organ

Since it is inactive after puberty, the thymus is at its largest during childhood (1oz.) and shrinks in size after puberty until it disappears. It will eventually be completely replaced by fat.

Thymosin is the hormone released by the thymus that stimulates the development of T-cells. White blood cells will enter the thymus throughout childhood and be transformed into T-cells. Once a T-cell has fully matured, it will move to a lymph node, attacking pathogens in the body. However, thymus cells can develop into cancerous cells.

The thymus contains 3 types of cells, which can develop into different forms of cancer:

Epithelial cells serve as the foundation for the thymus, providing its structure. Thymic carcinomas and thymomas develop from this type of cell.

Lymphocytes are the second part of the thymus, and can develop into the more well-known cancers, Hodgkin's lymphoma and non-Hodgkin's lymphoma.

The last type of cells are Kulchitsky cells, also known as neuroendocrine cells. These cells make up a small part of the thymus and are used to release hormones such as thymosin. These cells can develop carcinoid tumors.


Source:
Cancer.org
Endocrineweb.com
Photo by Sanja Gjenero

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap